Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Toxicol In Vitro
2024 Mar 01;95:105762. doi: 10.1016/j.tiv.2023.105762.
Show Gene links
Show Anatomy links
In vitro screening of per- and polyfluorinated substances (PFAS) for interference with seven thyroid hormone system targets across nine assays.
Degitz SJ, Olker JH, Denny JS, Degoey PP, Hartig PC, Cardon MC, Eytcheson SA, Haselman JT, Mayasich SA, Hornung MW.
???displayArticle.abstract???
The US Environmental Protection Agency is evaluating the ecological and toxicological effects of per- and polyfluorinated chemicals. A number of perfluorinated chemicals have been shown to impact the thyroid axis in vivo suggesting that the thyroid hormone system is a target of these chemicals. The objective of this study was to evaluate the activity of 136 perfluorinated chemicals at seven key molecular initiating events (MIE) within the thyroid axis using nine in vitro assays. The potential MIE targets investigated are Human Iodothyronine Deiodinase 1 (hDIO1), Human Iodothyronine Deiodinase 2 (hDIO2), Human Iodothyronine Deiodinase 3 (hDIO3), Xenopus Iodothyronine Deiodinase (xDIO3); Human Iodotyrosine Deiodinase (hIYD), Xenopus Iodotyrosine Deiodinase (xIYD), Human Thyroid Peroxidase (hTPO); and the serum binding proteins Human Transthyretin (hTTR) and Human Thyroxine Binding Globulin (hTBG). Of the 136 PFAS chemicals tested, 85 had sufficient activity to produce a half-maximal effect concentration (EC50) in at least one of the nine assays. In general, most of these PFAS chemicals did not have strong potency towards the seven MIEs examined, apart from transthyretin binding, for which several PFAS had potency similar to the respective model inhibitor. These data sets identify potentially active PFAS chemicals to prioritize for further testing in orthogonal in vitro assays and at higher levels of biological organization to evaluate their capacity for altering the thyroid hormone system and causing potential adverse health and ecological effects.
Butenhoff,
Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months.
2002, Pubmed
Butenhoff,
Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months.
2002,
Pubmed Butenhoff,
Evaluation of potential reproductive and developmental toxicity of potassium perfluorohexanesulfonate in Sprague Dawley rats.
2009,
Pubmed Butenhoff,
Gestational and lactational exposure to potassium perfluorooctanesulfonate (K+PFOS) in rats: developmental neurotoxicity.
2009,
Pubmed Butenhoff,
Toxicological evaluation of ammonium perfluorobutyrate in rats: twenty-eight-day and ninety-day oral gavage studies.
2012,
Pubmed Cai,
Thyromimetic action of the peroxisome proliferators clofibrate, perfluorooctanoic acid, and acetylsalicylic acid includes changes in mRNA levels for certain genes involved in mitochondrial biogenesis.
1996,
Pubmed Chang,
Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS).
2008,
Pubmed Chang,
Gestational and lactational exposure to potassium perfluorooctanesulfonate (K+PFOS) in rats: toxicokinetics, thyroid hormone status, and related gene expression.
2009,
Pubmed Coperchini,
Thyroid Disrupting Effects of Old and New Generation PFAS.
2020,
Pubmed Curran,
Altered fatty acid homeostasis and related toxicologic sequelae in rats exposed to dietary potassium perfluorooctanesulfonate (PFOS).
2008,
Pubmed Dong,
Hepatic miRNA profiles and thyroid hormone homeostasis in rats exposed to dietary potassium perfluorooctanesulfonate (PFOS).
2016,
Pubmed Graham,
Manipulation of adenovirus vectors.
1991,
Pubmed Guo,
Insight into antibody responses induced by plasmid or adenoviral vectors encoding thyroid peroxidase, a major thyroid autoantigen.
2003,
Pubmed Gutshall,
Mechanism of the serum thyroid hormone lowering effect of perfluoro-n-decanoic acid (PFDA) in rats.
1989,
Pubmed Hamilton,
The x-ray crystal structure refinements of normal human transthyretin and the amyloidogenic Val-30-->Met variant to 1.7-A resolution.
1993,
Pubmed Hornung,
Screening the ToxCast Phase 1 Chemical Library for Inhibition of Deiodinase Type 1 Activity.
2018,
Pubmed Houck,
Bioactivity profiling of per- and polyfluoroalkyl substances (PFAS) identifies potential toxicity pathways related to molecular structure.
2021,
Pubmed Janssen,
Directional thyroid hormone distribution via the blood stream to target sites.
2017,
Pubmed Köhrle,
Thyroid hormone system disrupting chemicals.
2021,
Pubmed Ladics,
90-day oral gavage toxicity study of 8-2 fluorotelomer alcohol in rats.
2008,
Pubmed Langley,
Thyroid, bradycardic and hypothermic effects of perfluoro-n-decanoic acid in rats.
1985,
Pubmed Lau,
Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation.
2003,
Pubmed Luebker,
Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters.
2005,
Pubmed Luongo,
Deiodinases and their intricate role in thyroid hormone homeostasis.
2019,
Pubmed Marchesini,
Biosensor discovery of thyroxine transport disrupting chemicals.
2008,
Pubmed Martin,
Toxicogenomic study of triazole fungicides and perfluoroalkyl acids in rat livers predicts toxicity and categorizes chemicals based on mechanisms of toxicity.
2007,
Pubmed Mayasich,
Xenopus laevis and human type 3 iodothyronine deiodinase enzyme cross-species sensitivity to inhibition by ToxCast chemicals.
2021,
Pubmed
,
Xenbase McLean,
Evolution of thyroid hormone distributor proteins.
2017,
Pubmed Miranda,
Effects of perfluorooctanoic acid (PFOA) on the thyroid status, vitellogenin, and oxidant-antioxidant balance in the Murray River rainbowfish.
2020,
Pubmed Montaño,
New approaches to assess the transthyretin binding capacity of bioactivated thyroid hormone disruptors.
2012,
Pubmed Moreno,
Genetics and phenomics of hypothyroidism and goiter due to iodotyrosine deiodinase (DEHAL1) gene mutations.
2010,
Pubmed Murk,
Mechanism-based testing strategy using in vitro approaches for identification of thyroid hormone disrupting chemicals.
2013,
Pubmed Noyes,
Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches.
2019,
Pubmed Olker,
In vitro screening for chemical inhibition of the iodide recycling enzyme, iodotyrosine deiodinase.
2021,
Pubmed Olker,
Screening the ToxCast Phase 1, Phase 2, and e1k Chemical Libraries for Inhibitors of Iodothyronine Deiodinases.
2019,
Pubmed Patlewicz,
Towards reproducible structure-based chemical categories for PFAS to inform and evaluate toxicity and toxicokinetic testing.
2022,
Pubmed Patlewicz,
A Chemical Category-Based Prioritization Approach for Selecting 75 Per- and Polyfluoroalkyl Substances (PFAS) for Tiered Toxicity and Toxicokinetic Testing.
2019,
Pubmed Paul,
Development of a thyroperoxidase inhibition assay for high-throughput screening.
2014,
Pubmed Paul Friedman,
Tiered High-Throughput Screening Approach to Identify Thyroperoxidase Inhibitors Within the ToxCast Phase I and II Chemical Libraries.
2016,
Pubmed Rabah,
Thyroid Hormone Distributor Proteins During Development in Vertebrates.
2019,
Pubmed Ramhøj,
Perfluorohexane Sulfonate (PFHxS) and a Mixture of Endocrine Disrupters Reduce Thyroxine Levels and Cause Antiandrogenic Effects in Rats.
2018,
Pubmed Ramhøj,
Evaluating thyroid hormone disruption: investigations of long-term neurodevelopmental effects in rats after perinatal exposure to perfluorohexane sulfonate (PFHxS).
2020,
Pubmed Ren,
Binding interactions of perfluoroalkyl substances with thyroid hormone transport proteins and potential toxicological implications.
2016,
Pubmed Renko,
An Improved Nonradioactive Screening Method Identifies Genistein and Xanthohumol as Potent Inhibitors of Iodothyronine Deiodinases.
2015,
Pubmed Seacat,
Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys.
2002,
Pubmed Smeltz,
Targeted Per- and Polyfluoroalkyl substances (PFAS) assessments for high throughput screening: Analytical and testing considerations to inform a PFAS stock quality evaluation framework.
2023,
Pubmed Smits,
Immunomodulation and hormonal disruption without compromised disease resistance in perfluorooctanoic acid (PFOA) exposed Japanese quail.
2013,
Pubmed Thibodeaux,
Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations.
2003,
Pubmed Van Rafelghem,
Effects of perfluorodecanoic acid on thyroid status in rats.
1987,
Pubmed Wang,
Interaction of PFOS and BDE-47 co-exposure on thyroid hormone levels and TH-related gene and protein expression in developing rat brains.
2011,
Pubmed Wang,
High-throughput screening and chemotype-enrichment analysis of ToxCast phase II chemicals evaluated for human sodium-iodide symporter (NIS) inhibition.
2019,
Pubmed Weiss,
Competitive binding of poly- and perfluorinated compounds to the thyroid hormone transport protein transthyretin.
2009,
Pubmed Yu,
Effects of perfluorooctane sulfonate on rat thyroid hormone biosynthesis and metabolism.
2009,
Pubmed Yu,
Perfluorooctane sulfonate increased hepatic expression of OAPT2 and MRP2 in rats.
2011,
Pubmed Zhang,
In Silico Approach To Identify Potential Thyroid Hormone Disruptors among Currently Known Dust Contaminants and Their Metabolites.
2015,
Pubmed Zhou,
Structural mechanism for the carriage and release of thyroxine in the blood.
2006,
Pubmed
